Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-25 @ 2:27 PM
Study NCT ID:
NCT05277766
Status:
RECRUITING
Last Update Posted:
2025-07-01
First Post:
2022-02-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
Sponsor:
University Hospital, Ghent
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-18
First Submit QC Date:
None
Study First Post Date:
2022-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-01
Last Update Post Date Type:
ACTUAL